Non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: A randomized, double-blind, sham-controlled ACT2 study
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Background: Clinical observations and results from recent studies support the use of non-invasive vagus nerve stimulation (nVNS) for treating cluster headache (CH) attacks. This study compared nVNS with a sham device for acute treatment in patients with episodic or chronic CH (eCH, cCH). Methods: After completing a 1-week run-in period, subjects were randomly assigned (1:1) to receive nVNS or sham therapy during a 2-week double-blind period. The primary efficacy endpoint was the proportion of all treated attacks that achieved pain-free status within 15 minutes after treatment initiation, without rescue treatment. Results: The Full Analysis Set comprised 48 nVNS-treated (14 eCH, 34 cCH) and 44 sham-treated (13 eCH, 31 cCH) subjects. For the primary endpoint, nVNS (14%) and sham (12%) treatments were not significantly different for the total cohort. In the eCH subgroup, nVNS (48%) was superior to sham (6%; p < 0.01). No significant differences between nVNS (5%) and sham (13%) were seen in the cCH subgroup. Conclusions: Combing both eCH and cCH patients, nVNS was no different to sham. For the treatment of CH attacks, nVNS was superior to sham therapy in eCH but not in cCH. These results confirm and extend previous findings regarding the efficacy, safety, and tolerability of nVNS for the acute treatment of eCH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The International Classification of Headache Disorders, 3rd edition (beta version)
Headache Classification Committee of the International Headache Society (IHS) (2013) · Cephalalgia · doi:10.1177/0333102413485658 · Cited by 8,229
Goadsby, P. J. (2004) · Cephalalgia · doi:10.1111/j.1468-2982.2004.00711.x · Cited by 2,381
Self-citationKalia, M., & Mesulam, M. (1980) · Journal of Comparative Neurology · doi:10.1002/cne.901930211 · Cited by 844 · cited 1×
“These data are consistent with an important sensory afferent role for the vagus nerve (21,22), and of its central projections (23).”
ResultAgostoni, E., Chinnock, J. E., Daly, M. D. B., & Murray, J. G. (1957) · The Journal of Physiology · doi:10.1113/jphysiol.1957.sp005703 · Cited by 688 · cited 1×
“These data are consistent with an important sensory afferent role for the vagus nerve (21,22), and of its central projections (23).”
ResultTreatment of Acute Cluster Headache with Sumatriptan
The Sumatriptan Cluster Headache Study Group* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250505 · Cited by 429
EFNS guidelines on the treatment of cluster headache and other trigeminal‐autonomic cephalalgias
May, A., Leone, M., Áfra, J., Linde, M., Sándor, P. S., Evers, S., & Goadsby, P. J. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01566.x · Cited by 413 · cited 7×
“This pivotal, randomized, double-blind, sham-controlled prospective study (NCT01958125) was conducted in four European countries at nine tertiary care sites, including academic medical centers and headache/pain/neurology clinics, between September 10, 2013, and October 14, 2014.”
BackgroundSelf-citationVagus Nerve and Vagus Nerve Stimulation, a Comprehensive Review: Part III
Yuan, H., & Silberstein, S. D. (2016) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.12649 · Cited by 381
Schoenen, J., Jensen, R. H., Lantéri-Minet, M., Láinez, M. J., Gaul, C., Goodman, A. M., Caparso, A., & May, A. (2013) · Cephalalgia · doi:10.1177/0333102412473667 · Cited by 358 · cited 1×
“Other neuromodulatory therapies, such as sphenopalatine ganglion stimulation (36,37), are becoming more established while the less recent approach of occipital nerve stimulation (28,38), has many practical challenges (39,40).”
BackgroundSelf-citationDodick, D., Lipton, R. B., Martin, V., Papademetriou, V., Rosamond, W., MaassenVanDenBrink, A., Loutfi, H., Welch, K. M., Goadsby, P. J., Hahn, S., et al. (2004) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2004.04078.x · Cited by 351 · cited 1×
“Triptans are relatively contraindicated in patients with cardiovascular disease (8).”
BackgroundSelf-citationVagus Nerve and Vagus Nerve Stimulation, a Comprehensive Review: Part II
Yuan, H., & Silberstein, S. D. (2016) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.12650 · Cited by 303 · cited 1×
“gammaCore was developed as a non-invasive vagus nerve stimulation (nVNS) device for transcutaneous stimulation of the cervical branch of the vagus nerve (14).”
MethodGaul, C., Diener, H.-C., Silver, N., Magis, D., Reuter, U., Andersson, A., Liebler, E. J., Straube, A., & on behalf of the PREVA Study Group (2016) · Cephalalgia · doi:10.1177/0333102415607070 · Cited by 279 · cited 6×
“Considering the refractory nature of cCH, it is perhaps not surprising that patients with this subtype may be less likely than those with eCH to respond to acute therapies (13,15,31).”
BackgroundMethodResultSelf-citationQuantitative studies of the vagus nerve in the cat. I. The ratio of sensory to motor fibers
Foley, J. O., & DuBois, F. S. (1937) · Journal of Comparative Neurology · doi:10.1002/cne.900670104 · Cited by 273 · cited 1×
“These data are consistent with an important sensory afferent role for the vagus nerve (21,22), and of its central projections (23).”
ResultSilberstein, S. D., Mechtler, L. L., Kudrow, D. B., Calhoun, A. H., McClure, C., Saper, J. R., Liebler, E. J., Rubenstein Engel, E., Tepper, S. J., & on Behalf of the ACT1 Study Group (2016) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.12896 · Cited by 263
Self-citationTreatment of Cluster Headache: The American Headache Society Evidence‐Based Guidelines
Robbins, M. S., Starling, A. J., Pringsheim, T. M., Becker, W. J., & Schwedt, T. J. (2016) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.12866 · Cited by 258 · cited 1×
“Other neuromodulatory therapies, such as sphenopalatine ganglion stimulation (36,37), are becoming more established while the less recent approach of occipital nerve stimulation (28,38), has many practical challenges (39,40).”
BackgroundNeuromodulation of chronic headaches: position statement from the European Headache Federation
Martelletti, P., Jensen, R. H., Antal, A., Arcioni, R., Brighina, F., de Tommaso, M., Franzini, A., Fontaine, D., Heiland, M., Jürgens, T. P., et al. (2013) · The Journal of Headache and Pain · doi:10.1186/1129-2377-14-86 · Cited by 210 · cited 1×
“Other neuromodulatory therapies, such as sphenopalatine ganglion stimulation (36,37), are becoming more established while the less recent approach of occipital nerve stimulation (28,38), has many practical challenges (39,40).”
BackgroundSelf-citationTowards a Definition of Intractable Headache for Use in Clinical Practice and Trials
Goadsby, P., Schoenen, J., Ferrari, M., Silberstein, S., & Dodick, D. (2006) · Cephalalgia · doi:10.1111/j.1468-2982.2006.01173.x · Cited by 196 · cited 1×
“A subset of patients with cCH may be refractory to prophylactic therapy after trials with several preventive options (27), which has led to invasive neuromodulatory approaches being considered (28,29).”
BackgroundSelf-citationVagus nerve stimulation therapy summary: Five years after FDA approval
Schachter, S. C. (2002) · Neurology · doi:10.1212/wnl.59.6_suppl_4.s15 · Cited by 178 · cited 2×
“Vagus nerve stimulation (VNS), a well-established neuromodulation treatment for epilepsy (10) and medication-resistant depression (11), has been successfully used open label in CH (12,13).”
BackgroundMethodLeft vagus nerve stimulation suppresses experimentally induced pain
Kirchner, A., Birklein, F., Stefan, H., & Handwerker, H. O. (2000) · Neurology · doi:10.1212/wnl.55.8.1167 · Cited by 163 · cited 1×
“Moreover, a role for vagal modulation in non-cranial pain has also been suggested by preclinical (24,25) and clinical studies (26).”
BackgroundOral zolmitriptan is effective in the acute treatment of cluster headache
Bahra, A., Gawel, M. J., Hardebo, J. E., Millson, D. S., Breen, S. A., & Goadsby, P. J. (2000) · Neurology · doi:10.1212/wnl.54.9.1832 · Cited by 156 · cited 1×
“Considering the refractory nature of cCH, it is perhaps not surprising that patients with this subtype may be less likely than those with eCH to respond to acute therapies (13,15,31).”
BackgroundSelf-citationEffectiveness of Intranasal Zolmitriptan in Acute Cluster Headache
Cittadini, E., May, A., Straube, A., Evers, S., Bussone, G., & Goadsby, P. J. (2006) · Archives of Neurology · doi:10.1001/archneur.63.11.nct60002 · Cited by 153 · cited 1×
“Evidence-based recommendations for acute CH therapy include the use of subcutaneous (4)/intranasal triptans (5,6) or inhaled oxygen (7).”
BackgroundSelf-citationInitial use of a novel noninvasive vagus nerve stimulator for cluster headache treatment
Nesbitt, A. D., Marin, J. C. A., Tompkins, E., Ruttledge, M. H., & Goadsby, P. J. (2015) · Neurology · doi:10.1212/wnl.0000000000001394 · Cited by 152
Self-citationLeft vagus nerve stimulation suppresses experimentally induced pain
Ness, T. J., Randich, A., Fillingim, R., Faught, R. E., & Backensto, E. M. (2001) · Neurology · doi:10.1212/wnl.56.7.985 · Cited by 148
Sleep and chronobiology in cluster headache
Barloese, M. C. J., Lund, N. L. T., Petersen, A. S., Rasmussen, M. K., Jennum, P., & Jensen, R. (2015) · Cephalalgia · doi:10.1177/0333102414564892 · Cited by 137 · cited 1×
“tertiary care centers) and the recruitment of subjects throughout the year rather than specifically when attack bouts are most common among patients with eCH, such as during seasonal transition periods (42).”
BackgroundSelf-citationLong-term effectiveness of sphenopalatine ganglion stimulation for cluster headache
Jürgens, T. P., Barloese, M. C. J., May, A., Laínez, J. M., Schoenen, J. E., Gaul, C., Goodman, A. M., Caparso, A., & Jensen, R. (2016) · Cephalalgia · doi:10.1177/0333102416649092 · Cited by 135 · cited 1×
“Other neuromodulatory therapies, such as sphenopalatine ganglion stimulation (36,37), are becoming more established while the less recent approach of occipital nerve stimulation (28,38), has many practical challenges (39,40).”
BackgroundSelf-citationNesbitt, A. D., & Goadsby, P. J. (2012) · BMJ · doi:10.1136/bmj.e2407 · Cited by 130
Self-citationMitsikostas, D. D., Edvinsson, L. I., Jensen, R., Katsarava, Z., Lampl, C., Negro, A., Osipova, V. В., Paemeleire, K., Sıva, A., Valade, D., et al. (2014) · The Journal of Headache and Pain · doi:10.1186/1129-2377-15-79 · Cited by 122 · cited 1×
“A consensus statement from the European Headache Federation has recommended appending the ICHD criteria to include a subclassification for refractory cCH (30).”
MethodSelf-citationMethodology of Clinical Trials of Sumatriptan in Migraine and Cluster Headache
Pilgrim, A. (2008) · European Neurology · doi:10.1159/000116757 · Cited by 117 · cited 1×
“Pain intensity was rated on a 5-point scale: 0, no pain to 4, very severe pain (19).”
BackgroundVagal afferent modulation of spinal nociceptive transmission in the rat
Ren, K., Randich, A., & Gebhart, G. F. (1989) · Journal of Neurophysiology · doi:10.1152/jn.1989.62.2.401 · Cited by 95 · cited 1×
“Moreover, a role for vagal modulation in non-cranial pain has also been suggested by preclinical (24,25) and clinical studies (26).”
BackgroundNonis, R., D’Ostilio, K., Schoenen, J., & Magis, D. (2017) · Cephalalgia · doi:10.1177/0333102417717470 · Cited by 90 · cited 1×
“By contrast, the sham device produced a low-frequency biphasic signal that could be felt as a variable tingling sensation but did not stimulate the vagus nerve (18).”
BackgroundCortical plasticity in episodic and chronic cluster headache
Naegel, S., Holle, D., Desmarattes, N., Theysohn, N., Diener, H., Katsarava, Z., & Obermann, M. (2014) · NeuroImage Clinical · doi:10.1016/j.nicl.2014.10.003 · Cited by 89 · cited 1×
“Brain anatomy differs between patients with cCH, and both healthy individuals and patients with eCH (32), while pain and sensory thresholds studied with quantitative sensory testing are no different between eCH and cCH (33).”
BackgroundSelf-citationAkerman, S., Simon, B. J., & Romero‐Reyes, M. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.03.004 · Cited by 87 · cited 2×
“nociception, VNS inhibited both spontaneous ongoing neuronal firing and firing in response to noxious dural or superior salivatory nucleus stimulation (20).”
BackgroundRen, K., Randich, A., & Gebhart, G. F. (1990) · Journal of Neurophysiology · doi:10.1152/jn.1990.64.4.1098 · Cited by 86 · cited 1×
“Moreover, a role for vagal modulation in non-cranial pain has also been suggested by preclinical (24,25) and clinical studies (26).”
BackgroundHealth-Related Quality of Life in Patients with Cluster Headache During Active Periods
D’Amico, D., Rigamonti, A., Solari, A., Leone, M., Usai, S., Grazzi, L., & Bussone, G. (2002) · Cephalalgia · doi:10.1046/j.1468-2982.2002.00463.x · Cited by 60 · cited 1×
“CH can also profoundly disturb quality of life by limiting patients’ functionality in work-related, domestic, and social activities (3).”
BackgroundQuantitative Sensory Testing in Cluster Headache: Increased Sensory Thresholds
Ladda, J., Straube, A. M., Förderreuther, S., Krause, P., & Eggert, T. (2006) · Cephalalgia · doi:10.1111/j.1468-2982.2006.01134.x · Cited by 59 · cited 1×
“Brain anatomy differs between patients with cCH, and both healthy individuals and patients with eCH (32), while pain and sensory thresholds studied with quantitative sensory testing are no different between eCH and cCH (33).”
BackgroundSelf-citationVagus nerve stimulation in treating depression: A tale of two stories.
Yuan, T., Li, A., Sun, X., Arias-Carrión, Ó., & Machado, S. E. D. C. (2016) · Current Molecular Medicine · doi:10.2174/1566524016666151222143609 · Cited by 23 · cited 1×
“Vagus nerve stimulation (VNS), a well-established neuromodulation treatment for epilepsy (10) and medication-resistant depression (11), has been successfully used open label in CH (12,13).”
MethodHow do we fashion better trials for neurostimulator studies in migraine?
Asano, E., & Goadsby, P. J. (2013) · Neurology · doi:10.1212/wnl.0b013e3182825174 · Cited by 10 · cited 1×
“The potential for unblinding is an inherent concern in the study of any medical device (41).”
BackgroundSelf-citation
Cited by
Dodick, D. W. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30478-1 · Cited by 557
Noninvasive vagus nerve stimulation as acute therapy for migraine: The randomized PRESTO study
Tassorelli, C., Grazzi, L., de Tommaso, M., Pierangeli, G., Martelletti, P., Rainero, I., Dorlas, S., Geppetti, P., Ambrosini, A., Sarchielli, P., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000005857 · Cited by 254
Self-citation
Metadata
- Authors
- Goadsby, P. J., de Coo, I. F., Silver, N., Tyagi, A., Ahmed, F., Gaul, C., Jensen, R. H., Diener, H.-C., Solbach, K., Straube, A., Liebler, E., Marin, J. C., & Ferrari, M. D.
- Venue
- Cephalalgia
- Publisher
- SAGE Publications
- Published
- 2017-12-12
- Volume
- 38
- Issue
- 5
- Pages
- 959-969
- ISSN
- 0333-1024 (ISSN-L)
- 1468-2982
- OpenAlex
- W2774831914
- Cited by
- 203
- References
- 37
- FWCI
- 18.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.